UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival

NEJM evidence, 2024-08, Vol.3 (8), p.EVIDoa2300267

2024

Volltextzugriff (PDF)

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Breast cancer research : BCR, 2022-11, Vol.24 (1), p.74-74, Article 74

2022

Volltextzugriff (PDF)

Correlation of the oncotype DX breast recurrence score and the ki-67 IHC MIB-1 pharmDX score in HR+, HER2-, node-positive early breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12556-e12556

2022

Volltextzugriff (PDF)

Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD15-05-PD15-05

2022

Volltextzugriff (PDF)

Reply to K. Ando et al

Journal of clinical oncology, 2021-06, Vol.39 (17), p.JCO2100424-1948

2021

Volltextzugriff (PDF)

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer

Journal of clinical oncology, 2021-02, Vol.39 (6), p.557-564

2021

Volltextzugriff (PDF)

Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS4-10-GS4-10

2021

Volltextzugriff (PDF)

Adverse pathology at radical prostatectomy, GPS™ test, and clinical/pathology features as predictors of long-term prostate cancer outcomes

European urology open science (Online), 2020-07, Vol.19, p.e1661

2020

Volltextzugriff (PDF)

17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1549-1557

2020

Volltextzugriff (PDF)

Critically Ill Patients with End-Stage Liver Disease

Emergency medicine clinics of North America, 2019-08, Vol.37 (3), p.511-527

Crager, Sara, MD

2019

Volltextzugriff (PDF)

Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.262-262

2019

Volltextzugriff (PDF)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

Breast cancer research and treatment, 2018-06, Vol.169 (2), p.359-369

2018

Volltextzugriff (PDF)

The pitfalls of using the 2010 American college of rheumatology/European league against rheumatism (acr/eular) classification criteria for diagnosis of rheumatoid arthritis

Rheumatology and Orthopedic Medicine, 2018, Vol.3 (4)

2018

Volltextzugriff (PDF)

Abstract PD7-07: Discovery of molecular predictors of late breast cancer specific events (BCSE) in ER+, node+ breast cancer – new transcriptome expression whole gene analysis of the phase III adjuvant trial SWOG S8814

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.PD7-07-PD7-07

2017

Volltextzugriff (PDF)

Alternatives to the Conference Status Quo: Addressing the Learning Needs of Emergency Medicine Residents

Annals of emergency medicine, 2016-10, Vol.68 (4), p.423-430

2016

Volltextzugriff (PDF)

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score

Urology (Ridgewood, N.J.), 2016-03, Vol.89, p.69-75

2016

Volltextzugriff (PDF)

Abstract S3-02: Molecular predictors of outcome on adjuvant CAF plus tamoxifen (T) vs T in postmenopausal patients (pts) with ER+, node+ breast cancer – Transcriptome expression analysis of the phase III trial SWOG-8814

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S3-S3-02

2016

Volltextzugriff (PDF)

Abstract P5-07-01: Successful whole transcriptome analysis of 25-year-old breast tumor samples from the phase III trial SWOG-8814 by next generation sequencing (NGS): Standardized analytical methods for exploratory and validation studies

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-07-01

2016

Volltextzugriff (PDF)

Patient-specific meta-analysis (MA) of two validation studies to predict pathologic outcomes in prostate cancer (PCa) using a 17-gene genomic prostate score (GPS)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.100-100

2016

Volltextzugriff (PDF)

Abstract 14: Analysis of tumor DNA in urine as a highly sensitive liquid biopsy for patients with non-muscle invasive bladder cancer (NMIBC)

Clinical cancer research, 2016-01, Vol.22 (1_Supplement), p.14-14

2016

Volltextzugriff (PDF)

Taking the “Goal-Directed” Out of Early Goal-Directed Therapy for Sepsis?

Annals of emergency medicine, 2015-08, Vol.66 (2), p.201-211

Crager, Sara E., MD

2015

Volltextzugriff (PDF)

Abstract P4-02-08: Global quantitative measures using next-generation sequencing for breast cancer presence outperform individual tumor markers in plasma

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-02-08

2015

Volltextzugriff (PDF)

Taking the “Goal-Directed” Out of Early Goal-Directed Therapy for Sepsis?

Annals of emergency medicine, 2015-03, Vol.65 (3), p.339-340

Crager, Sara E., MD

2015

Volltextzugriff (PDF)

Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water

Clinical infectious diseases, 2012-11, Vol.55 (9), p.e79-e85

2012

Volltextzugriff (PDF)

PD03-09: Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next Generation Sequencing in 136 Patients

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD03-09-PD03-09

2011

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(46)
magazinearticle
(1)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(13)
Female
(9)
Male
(9)
Biological And Medical Sciences
(6)
Middle Aged
(6)
Adult
(5)
Aged
(5)
Prognosis
(5)
Animals
(4)
Emergency
(4)
Oncology
(4)
Diagnosis
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Medical Sciences
(3)
Antihypertensive Agents - Therapeutic Use
(2)
Biology
(2)
Blood Pressure
(2)
Breast Cancer
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Correlation of the oncotype DX breast recurrence score and the ki-67 IHC MIB-1 pharmDX score in HR+, HER2-, node-positive early breast cancer

Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42

Reply to K. Ando et al

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer

Abstract GS4-10: Development and validation of a tool integrating the 21-gene recurrence score and clinicopathlogic features to individualize prognosis for distant recurrence and prediction of absolute chemotherapy benefit in early breast cancer

Adverse pathology at radical prostatectomy, GPS™ test, and clinical/pathology features as predictors of long-term prostate cancer outcomes

17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort

Critically Ill Patients with End-Stage Liver Disease

Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

The pitfalls of using the 2010 American college of rheumatology/European league against rheumatism (acr/eular) classification criteria for diagnosis of rheumatoid arthritis

Abstract PD7-07: Discovery of molecular predictors of late breast cancer specific events (BCSE) in ER+, node+ breast cancer – new transcriptome expression whole gene analysis of the phase III adjuvant trial SWOG S8814

Alternatives to the Conference Status Quo: Addressing the Learning Needs of Emergency Medicine Residents

Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score

Abstract S3-02: Molecular predictors of outcome on adjuvant CAF plus tamoxifen (T) vs T in postmenopausal patients (pts) with ER+, node+ breast cancer – Transcriptome expression analysis of the phase III trial SWOG-8814

Abstract P5-07-01: Successful whole transcriptome analysis of 25-year-old breast tumor samples from the phase III trial SWOG-8814 by next generation sequencing (NGS): Standardized analytical methods for exploratory and validation studies

Patient-specific meta-analysis (MA) of two validation studies to predict pathologic outcomes in prostate cancer (PCa) using a 17-gene genomic prostate score (GPS)

Abstract 14: Analysis of tumor DNA in urine as a highly sensitive liquid biopsy for patients with non-muscle invasive bladder cancer (NMIBC)

Taking the “Goal-Directed” Out of Early Goal-Directed Therapy for Sepsis?

Abstract P4-02-08: Global quantitative measures using next-generation sequencing for breast cancer presence outperform individual tumor markers in plasma

Taking the “Goal-Directed” Out of Early Goal-Directed Therapy for Sepsis?

Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water

PD03-09: Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next Generation Sequencing in 136 Patients

Suchergebnisse filtern